Ideas to Action:

Independent research for global prosperity

CGD Policy Blogs


An image of money, a calculator, and a stethoscope.

Corrective Taxes to Save Lives

Governments use corrective taxes to reduce the use of products that harm well-being and create costs not just to society at large (externalities) but also to individual consumers who may underestimate the future health consequences of their current consumption. Taxes on gas to reduce pollution or on carbon dioxide emissions to reduce greenhouse gases are classic examples of this approach.

Quality Medicines Use Data Can Lead to Better Health Systems, and Better Outcomes

In this blog, we provide a rapid overview of the sources and wider uses of medicines data to strengthen health systems in LMIC settings, with a focus on Ghana. We argue that having credible and comprehensive data on medicines use leads to better decision making and better medicines policy. These are necessary—although not sufficient—pre-conditions to improve health outcomes in a financially sustainable way. 

The Collateral Health Impacts of COVID-19: a Disproportionate Impact on Girls and Women

In this recent policy paper, we examined 247 studies published between January and March 2021 that contained empirical analyses and covered gender-focused aspects of mental health, COVID-19 knowledge, attitudes and practices, COVID-19 clinical outcomes, maternal and child health, and sexual and reproductive health. We find that the pandemic causes disproportionate negative impacts on the well-being of women and girls relative to that of men and boys. This blog summarises the main considerations.

Timeline of key events and milestones

Lessons for R&D and Manufacturing Investment for Equitable COVID-19 and Pandemic Response

We conducted a joint review of the portfolio management activities of the committee overseeing COVAX R&D and manufacturing investments, known as RDMIC (R&D and Manufacturing Investment Committee). Our aim was to assess learnings from investments to date and suggest ways to strengthen future global health security preparedness and prevent the inequities observed in the COVID-19 response from repeating.

We Should Track Global Vaccine Manufacturing Better - Here Is Why, and How

Poor understanding about vaccine capacity was one of the reasons why the world did not have the infrastructure needed to manufacture sufficient doses. This blogs proposes three actions to start tracking manufacturing capacity better and create robust estimates for the world’s vaccine manufacturing capacity.